​It is with great enthusiasm that the journal announces Drs. Lashner and Cominelli as the new Co-Editors-in-Chief of Inflammatory Bowel Diseases. Read their first full editorial in the journal where they express their vision in making IBD "the home for the most important research advances, interesting innovations in patient treatment, and resolution of timely controversies.." in the field.

 
Bret A. Lashner, M.D., M.P.H     Fabio Cominelli, M.D., Ph.D.

Current Issue Highlights

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases

Ghosh, Subrata; Louis, Edouard; Beaugerie, Laurent; More

Inflammatory Bowel Diseases . 23(3):333-340, March 2017.


Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study

Poojary, Priti; Saha, Aparna; Chauhan, Kinsuk; More

Inflammatory Bowel Diseases . 23(3):347-356, March 2017.


Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial

Carlsen, Katrine; Jakobsen, Christian; Houen, Gunnar; More

Inflammatory Bowel Diseases . 23(3):357-365, March 2017.


Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis

Huang, Yong; Dalal, Sushila; Antonopoulos, Dionysios; More

Inflammatory Bowel Diseases . 23(3):366-378, March 2017.


Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

Kopylov, Uri; Ron, Yulia; Avni-Biron, Irit; More

Inflammatory Bowel Diseases . 23(3):404-408, March 2017.


Letters to the Editor